Covance Prevails in PETA Lawsuit; Court Enters Order Requiring PETA to Comply With Ban on Infiltration

Oct 17, 2005, 01:00 ET from Covance

    PRINCETON, N.J., Oct. 17 /PRNewswire-FirstCall/ -- Covance (NYSE:   CVD)
 today achieved a successful settlement to its lawsuit against PETA, in which
 PETA agreed to a ban on conducting any infiltration of Covance for five years.
 In addition, PETA's operative, Lisa Leitten, accepted a three-year ban on
 infiltrating any commercial animal research facility worldwide.  PETA and
 Leitten must also provide all video footage and written notes taken from
 Covance.  The settlement was confirmed by the Circuit Court of Fairfax County,
 which entered an order requiring PETA and Leitten to comply with these
     "This resolution achieves our key goals of the lawsuit: to obtain a ban on
 infiltration and to demonstrate that Covance will not tolerate such unlawful
 acts by those who seek to block important biomedical research," said James
 Lovett, Senior Vice President and General Counsel at Covance.  "The strength
 of our case enabled us to achieve these goals quickly via this settlement."
     "Our business is devoted to helping develop new medicines for diseases
 such as breast cancer, diabetes, leukemia, Alzheimer's, heart disease and
 HIV/AIDS," said Lovett.  "The research we perform is essential to ensuring
 that these medicines are safe and effective before they are made available to
     A copy of the settlement can be found at
     Covance, with headquarters in Princeton, New Jersey, is one of the world's
 largest and most comprehensive drug development services companies with annual
 revenues greater than $1 billion, global operations in 17 countries, and more
 than 7,000 employees worldwide.  Information on Covance's products and
 services, recent press releases, and SEC filings can be obtained through its
 website at

SOURCE Covance